BUAP hosts International Translational Research Symposium 2026

The Faculty of Medicine at the Benemérita Universidad Autónoma de Puebla (BUAP) is hosting the International Translational Research Symposium 2026. Held from October 28 to 30, the event aims to bridge the gap between basic science and clinical application through keynote lectures, thematic tables, poster sessions, and academic competitions.

Recognized researchers are presenting advancements across nine thematic areas, including translational oncology, metabolic diseases, immunology, autoimmune diseases, regenerative medicine, and gene therapy. Celso Enrique Cortés Romero, director of the Faculty of Medicine, stated the symposium is intended to foster academic benefits and consolidate collaborations to improve medical practice.

During a keynote lecture, UNAM researcher Víctor Manuel Castaño Meneses highlighted a stagnation in drug development. He noted that while approximately four million scientific articles are published annually—half of which are medical—drug patent rates remain static, with over 80 percent of current medications having been developed 40 years ago. Castaño Meneses emphasized the urgent need to promote translational medicine to address this lag.